BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

FHLCvsFTXHETF Comparison

ETF 1

FHLC

Fidelity MSCI Health Care Index ETF

This fund is part of

US Health Care

+1.78%

Full FHLC fund page

VS

ETF 2

FTXH

First Trust Nasdaq Pharmaceuticals ETF

This fund is part of

US Health Care

+1.78%

Full FTXH fund page

Fidelity MSCI Health Care Index ETF (FHLC) and First Trust Nasdaq Pharmaceuticals ETF (FTXH) belong to the same industry segment: US Health Care. FHLC's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. In contrast, FTXH's top sector exposures are Healthcare, FHLC is less expensive with a Total Expense Ratio (TER) of 0.084%, versus 0.6% for FTXH. FHLC is up 7.45% year-to-date (YTD) with +$252M in YTD flows. FTXH performs better with 20.86% YTD performance, and +$890M in YTD flows. Run a side-by-side ETF comparison of FHLC and FTXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

FHLC vs FTXH performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 07/27/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	FHLC FTXH	+1.41%+3.05%	+14.62%+18.72%	+7.45%+20.86%	+25.17%+49.94%	+29.59%+55.38%	+29.91%+59.22%
Flows	FHLC FTXH	-$3M+$880M	+$81M+$881M	+$252M+$890M	+$299M+$893M	-$441M+$882M	-$76M+$885M

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	FHLC FTXH	+17.41%+18.15%	+15.28%+17.09%	+14.37%+16.60%	+15.26%+16.10%
Max drawdown	FHLC FTXH	-3.84%-4.43%	-10.35%-7.50%	-16.88%-19.32%	-17.78%-19.32%
Max drawdown duration	FHLC FTXH	20d20d	169d99d	435d393d	762d393d

Trading data

Create an account to view trading data

Join for free

	FHLC	FTXH
Last sale 7/29/2026 at 7:06 PM	$80.81	$39.58
Previous close 07/28/2026	$81.00	$39.69
Consolidated volume 07/28/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of June 30, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free

	FHLC	FTXH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 7/29/2026 at 7:06 PM

Live

Closed

	FHLC	FTXH
Last price	$80.81	$39.58
1D performance	-0.23%	-0.26%
AuM	$3.30 B	$933.35 M
E/R	0.084%	0.6%

Characteristics

	FHLC	FTXH
Management strategy	Passive	Passive
Provider	Fidelity	First Trust
Benchmark	MSCI USA IMI Health Care 25/50 Index	NASDAQ US Smart Pharmaceuticals Index
N° of holdings	333	50
Asset class	-	Equities
Trailing 12m distribution yield	Join	Join
Inception date	October 21, 2013	September 20, 2016
ESG	No	No

More FHLC data on Trackinsight

More FTXH data on Trackinsight

Exposure

Countries

FHLC

USA

96.98%

Other

3.02%

FTXH

USA

95.49%

Other

4.51%

Sectors

FHLC

Healthcare

97.66%

Other

2.34%

FTXH

Healthcare

99.86%

Other

0.14%

Diversification

FHLC

Total weight of top 15 holdings out of 15

61.21%

FTXH

Total weight of top 15 holdings out of 15

66.57%

Top 15 holdings

Data as of June 30, 2026

FHLC

Eli Lilly & Co.

13.60%

Johnson & Johnson

8.86%

AbbVie, Inc.

6.46%

UnitedHealth Group, Inc.

5.67%

Merck & Co., Inc.

4.66%

Amgen, Inc.

2.86%

Thermo Fisher Scientific, Inc.

2.82%

Abbott Laboratories

2.44%

Gilead Sciences, Inc.

2.31%

Intuitive Surgical, Inc.

2.13%

Pfizer Inc.

2.02%

CVS Health Corp.

2.00%

Danaher Corp.

1.84%

Vertex Pharmaceuticals, Inc.

1.83%

Bristol Myers Squibb Co.

1.70%

FTXH

Eli Lilly & Co.

7.74%

AbbVie, Inc.

7.39%

Johnson & Johnson

6.98%

Merck & Co., Inc.

6.92%

Bristol Myers Squibb Co.

6.18%

Biogen, Inc.

3.73%

Viatris, Inc.

3.70%

Cardinal Health, Inc.

3.54%

Vertex Pharmaceuticals, Inc.

3.42%

Amgen, Inc.

3.18%

Pfizer Inc.

2.95%

Gilead Sciences, Inc.

2.89%

United Therapeutics Corp.

2.76%

Regeneron Pharmaceuticals, Inc.

2.73%

Jazz Pharmaceuticals Plc

2.46%

Frequently asked questions about FHLC and FTXH

How have the FHLC and FTXH ETFs performed in 2026?

As of July 27, 2026, FHLC is up 7.45% year-to-date (YTD), while FTXH has returned 20.86%. That puts FTXH better performer ahead so far this year.

Which ETF is attracting more investor money: FHLC or FTXH?

Year-to-date, the FHLC ETF saw +$252M in flows, compared to +$890M for FTXH.

Which ETF is more volatile: FHLC or FTXH?

Over the past year, FHLC had a volatility of 15.28%, while FTXH experienced 17.09%.

Which ETF is bigger: FHLC or FTXH?

As of July 27, 2026, FHLC holds $3.30 B in assets under management (AUM), while FTXH manages $933.35 M.

What sectors do the FHLC and FTXH ETFs invest in?

FHLC leans toward sectors like Healthcare. Meanwhile, FTXH focuses on Healthcare.

What are the top holdings of the FHLC ETF and FTXH ETF?

FHLC top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. FTXH holds in its top three: Eli Lilly & Co., AbbVie, Inc. and Johnson & Johnson.

FHLCvsFTXHETF Comparison

Fidelity MSCI Health Care Index ETF

First Trust Nasdaq Pharmaceuticals ETF

FHLC vs FTXH performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the FHLC and FTXH ETFs performed in 2026?

As of July 27, 2026, FHLC is up 7.45% year-to-date (YTD), while FTXH has returned 20.86%. That puts FTXH better performer ahead so far this year.

Which ETF is attracting more investor money: FHLC or FTXH?

Year-to-date, the FHLC ETF saw +$252M in flows, compared to +$890M for FTXH.

Which ETF is more volatile: FHLC or FTXH?

Over the past year, FHLC had a volatility of 15.28%, while FTXH experienced 17.09%.

Which ETF is bigger: FHLC or FTXH?

As of July 27, 2026, FHLC holds $3.30 B in assets under management (AUM), while FTXH manages $933.35 M.

What sectors do the FHLC and FTXH ETFs invest in?

FHLC leans toward sectors like Healthcare. Meanwhile, FTXH focuses on Healthcare.

What are the top holdings of the FHLC ETF and FTXH ETF?

FHLC top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. FTXH holds in its top three: Eli Lilly & Co., AbbVie, Inc. and Johnson & Johnson.

Which ETF is more diversified: FHLC or FTXH?

FHLC holds 337 securities with 61.21% of its assets in the top 15. FTXH has 50 securities and a top 15 weight of 66.57%.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up